Coronavirus: The questions that remain about Moderna’s COVID-19 vaccine A second experimental COVID-19 vaccine — this one from Moderna Inc. — yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.
Moderna said its vaccine appears to be 94.5 per cent effective, according to preliminary data from an ongoing study. A week ago, competitor Pfizer Inc. announced its own vaccine looked 90 per cent effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.
Carolyn Jarvis looks at the questions that still remain about the potential vaccine.
For more info, please go to https://globalnews.ca/news/7464825/coronavirus-vaccine-moderna-update/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB